These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 25428209)

  • 1. Management of vascular risk factors in the Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST).
    Meschia JF; Voeks JH; Leimgruber PP; Mantese VA; Timaran CH; Chiu D; Demaerschalk BM; Howard VJ; Hughes SE; Longbottom M; Howard AG; Brott TG
    J Am Heart Assoc; 2014 Nov; 3(6):e001180. PubMed ID: 25428209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal Medical Management Reduces Risk of Disease Progression and Ischemic Events in Asymptomatic Carotid Stenosis Patients: A Long-Term Follow-Up Study.
    Shah Z; Masoomi R; Thapa R; Wani M; Chen J; Dawn B; Rymer M; Gupta K
    Cerebrovasc Dis; 2017; 44(3-4):150-159. PubMed ID: 28689200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk Factor Control in Stroke Survivors with Diagnosed and Undiagnosed Diabetes: A Ghanaian Registry Analysis.
    Sarfo FS; Akassi J; Agyei M; Kontoh S; Ovbiagele B
    J Stroke Cerebrovasc Dis; 2020 Dec; 29(12):105304. PubMed ID: 32992189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carotid revascularization and medical management for asymptomatic carotid stenosis: Protocol of the CREST-2 clinical trials.
    Howard VJ; Meschia JF; Lal BK; Turan TN; Roubin GS; Brown RD; Voeks JH; Barrett KM; Demaerschalk BM; Huston J; Lazar RM; Moore WS; Wadley VG; Chaturvedi S; Moy CS; Chimowitz M; Howard G; Brott TG;
    Int J Stroke; 2017 Oct; 12(7):770-778. PubMed ID: 28462683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular risk factor control is insufficient in young patients with coronary artery disease.
    Christiansen MK; Jensen JM; Brøndberg AK; Bøtker HE; Jensen HK
    Vasc Health Risk Manag; 2016; 12():219-27. PubMed ID: 27307744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Achievement of multiple therapeutic targets for cardiovascular disease prevention: Retrospective analysis of real practice in Italy.
    Figliuzzi I; Presta V; Citoni B; Miceli F; Simonelli F; Battistoni A; Coluccia R; Ferrucci A; Volpe M; Tocci G
    Clin Cardiol; 2018 Jun; 41(6):788-796. PubMed ID: 29604091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationale, Design, and Implementation of Intensive Risk Factor Treatment in the CREST2 Trial.
    Turan TN; Voeks JH; Chimowitz MI; Roldan A; LeMatty T; Haley W; Lopes-Virella M; Chaturvedi S; Jones M; Heck D; Howard G; Lal BK; Meschia JF; Brott TG
    Stroke; 2020 Oct; 51(10):2960-2971. PubMed ID: 32951538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mediators of the Age Effect in the Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST).
    Voeks JH; Howard G; Roubin G; Farb R; Heck D; Logan W; Longbottom M; Sheffet A; Meschia JF; Brott TG
    Stroke; 2015 Oct; 46(10):2868-73. PubMed ID: 26351359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complication rates and center enrollment volume in the carotid revascularization endarterectomy versus stenting trial.
    Gonzales NR; Demaerschalk BM; Voeks JH; Tom M; Howard G; Sheffet AJ; Garcia L; Clair DG; Barr J; Orlow S; Brott TG;
    Stroke; 2014 Nov; 45(11):3320-4. PubMed ID: 25256180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical need, design, and goals for the Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis trial.
    Lal BK; Meschia JF; Brott TG
    Semin Vasc Surg; 2017 Mar; 30(1):2-7. PubMed ID: 28818255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes is not a predictor of outcome for carotid revascularization with stenting as it may be for carotid endarterectomy.
    Parlani G; De Rango P; Cieri E; Verzini F; Giordano G; Simonte G; Isernia G; Cao P
    J Vasc Surg; 2012 Jan; 55(1):79-89; discussion 88-9. PubMed ID: 22056251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in utilization of lipid- and blood pressure-lowering agents and goal attainment among the U.S. diabetic population, 1999-2008.
    Kuznik A; Mardekian J
    Cardiovasc Diabetol; 2011 Apr; 10():31. PubMed ID: 21496321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Multifactorial Treatment Targets and Relative Importance of Hemoglobin A1c, Blood Pressure, and Low-Density Lipoprotein-Cholesterol on Cardiovascular Diseases in Chinese Primary Care Patients With Type 2 Diabetes Mellitus: A Population-Based Retrospective Cohort Study.
    Wan EYF; Fung CSC; Yu EYT; Chin WY; Fong DYT; Chan AKC; Lam CLK
    J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temporal Changes in Periprocedural Events in the Carotid Revascularization Endarterectomy Versus Stenting Trial.
    Howard G; Hopkins LN; Moore WS; Katzen BT; Chakhtoura E; Morrish WF; Ferguson RD; Hye RJ; Shawl FA; Harrigan MR; Voeks JH; Howard VJ; Lal BK; Meschia JF; Brott TG
    Stroke; 2015 Aug; 46(8):2183-9. PubMed ID: 26173731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term follow-up study of endarterectomy versus angioplasty in patients with symptomatic severe carotid stenosis trial.
    Mas JL; Arquizan C; Calvet D; Viguier A; Albucher JF; Piquet P; Garnier P; Viader F; Giroud M; Hosseini H; Hinzelin G; Favrole P; Hénon H; Neau JP; Ducrocq X; Padovani R; Milandre L; Rouanet F; Wolff V; Saudeau D; Mahagne MH; Sablot D; Amarenco P; Larrue V; Beyssen B; Leys D; Moulin T; Lièvre M; Chatellier G;
    Stroke; 2014 Sep; 45(9):2750-6. PubMed ID: 25082808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological management of modifiable cardiovascular risk factors (blood pressure and lipids) following diagnosis of myocardial infarction, stroke and diabetes: comparison between population-based studies in Russia and Norway.
    Cook S; Hopstock LA; Eggen AE; Bates K; Iakunchykova O; Kontsevaya A; McKee M; Schirmer H; Voevoda M; Kudryavtsev AV; Malyutina S; Leon DA
    BMC Cardiovasc Disord; 2020 May; 20(1):234. PubMed ID: 32430002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Issues to Be Addressed and Hopefully Resolved in the Carotid Revascularization Endarterectomy Versus Stenting Trial 2.
    Moore WS
    Angiology; 2016 May; 67(5):408-10. PubMed ID: 26460327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critique of the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST): flaws in CREST and its interpretation.
    Paraskevas KI; Mikhailidis DP; Liapis CD; Veith FJ
    Eur J Vasc Endovasc Surg; 2013 Jun; 45(6):539-45. PubMed ID: 23602856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Asymptomatic carotid artery disease: A personalized approach to management.
    Schenone AL; Cohen A; Shishehbor MH
    Cleve Clin J Med; 2015 Dec; 82(12):855-63. PubMed ID: 26651895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk Factors For Stroke, Myocardial Infarction, or Death Following Carotid Endarterectomy: Results From the International Carotid Stenting Study.
    Doig D; Turner EL; Dobson J; Featherstone RL; de Borst GJ; Stansby G; Beard JD; Engelter ST; Richards T; Brown MM;
    Eur J Vasc Endovasc Surg; 2015 Dec; 50(6):688-94. PubMed ID: 26460291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.